close :

:

Forgotten your password?
 
Pharma Industry News
Printable Version   Email to a friend

Vitamin A for Diabetic Foot Ulcers

November 26, 2005

Tretinoin, a vitamin A compound usually used in the treatment of acne, has been shown to assist in healing foot ulcers in people with diabetes, according to a report recently published in the Archives of Dermatology and reported by Reuters.

In previous studies, topically applied Retin-A (tretinoin) enhanced wound-healing in people with diabetes. However, these studies were small and produced some inconsistent results.

"We wanted to know if tretinoin really helps or not," Dr Tissa R Hata of the Department of Medicine, University of California, San Diego, reportedly told Reuters Health.

The more recent clinical trial included a total of 24 volunteers with diabetic foot ulcers, but none of these participants showed evidence of infection or circulation problems in the extremities. Each participant was randomly assigned to receive either daily treatment with topical tretinoin solution (0.05%) or placebo (a saline solution) over a period of four weeks.

Photographs were taken and the size of each wound was assessed every two weeks for a period of 16 weeks.

A total of 22 participants completed the study, among whom was a total of 24 foot ulcers. At the end of 16 weeks, two of the 11 ulcers in the control group (18%) and 6 of the 13 ulcers in the treated group (46%) had completely healed.

No statistically significant adverse events occurred during the course of the study, although some patients reporting experiencing mild pain at the site of the ulcer.

"We are very pleased with the results. We were a bit concerned because tretinoin is very irritating and we thought that the patients would become so irritated that we wouldn't be able to continue the study. But actually, that didn't seem to be a problem in most cases," Hata said, according to Reuters. "The patients seemed to get used to it."

"We are hoping that diabetic foot clinics will adopt some of this, and use [Retin-A] when some of the other therapies that they are using don't work," she concluded.

Sources:
Vitamin A compound heals diabetic foot ulcers, Reuters, 23 November, 2005.
The Effect of Short-Contact Topical Tretinoin Therapy for Foot Ulcers in Patients With Diabetes. Wynnis L Tom, MD, et al. Archives of Dermatology, volume141, pages 1373-1377, 2005.

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 24, 2008
Audience: Infectious disease and medical genetics healthcare professionals[Posted 07/24/2008] FDA informed healthcare...
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...